# FDA recall D-0375-2022

> **Taro Pharmaceuticals U.S.A., Inc.** · Class I · drug recall initiated 2021-12-15.

## Product

Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3

## Reason for recall

Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria

## Distribution

Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.

## Key facts

- **Recall number:** D-0375-2022
- **Recalling firm:** Taro Pharmaceuticals U.S.A., Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-12-15
- **Report date:** 2022-01-19
- **Termination date:** 2023-12-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hawthorne, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0375-2022

## Citation

> AI Analytics. FDA recall D-0375-2022. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-0375-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*